BIOS Capital Management

Latest statistics and disclosures from BIOS Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ACTU, CGTX, IRD, LTRN, RNTX, and represent 99.30% of BIOS Capital Management's stock portfolio.
  • Added to shares of these 1 stock: ACTU.
  • Reduced shares in these 1 stock: LTRN.
  • BIOS Capital Management was a net buyer of stock by $306k.
  • BIOS Capital Management has $89M in assets under management (AUM), dropping by 22.51%.
  • Central Index Key (CIK): 0001813845

Tip: Access up to 7 years of quarterly data

Positions held by BIOS Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for BIOS Capital Management

BIOS Capital Management holds 6 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Actuate Therapeutics (ACTU) 75.6 $67M 10M 6.69
 View chart
Cognition Therapeutics (CGTX) 9.1 $8.1M 6.0M 1.35
 View chart
Ocuphire Pharma (IRD) 7.4 $6.6M 3.7M 1.79
 View chart
Lantern Pharma (LTRN) 5.0 $4.4M -5% 1.0M 4.35
 View chart
Rein Therapeutics Com New (RNTX) 2.2 $1.9M 1.7M 1.15
 View chart
In8bio 0.7 $622k 287k 2.17
 View chart

Past Filings by BIOS Capital Management

SEC 13F filings are viewable for BIOS Capital Management going back to 2024